• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Spectrum Solutions Collaborates with UCLA School of Dentistry

    Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization

    Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty

    Twist on Heart Valve Design Boosts Blood Flow, Prevents Clots

    FDA Clears 3D Acellular Dermal Matrix
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    MW Life Sciences

    K-Tube Technologies

    FUTEK Advanced Sensor Technology Inc.

    Spectrum Plastics Group

    Qosina Corp.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    MW Life Sciences

    PTI Engineered Plastics Inc.

    Spectrum Plastics Group

    Unicep

    Creganna Medical, part of TE Connectivity
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Features

    When Do I Really Need to Perform an EO Requalification?

    An examination of the changes in ANSI/AAMI/ISO 11135:2014.

    When Do I Really Need to Perform an EO Requalification?
    A Nelson Labs analyst performing a sterility test.
    Related CONTENT
    • Extractable/Leachable Chemistry Testing Strategies for Medical Devices
    • Qosina Adds New Y Connector Hemostasis Valves
    • TSO3 Receives U.S. Clearance for Extended Claims for Its Medical Device Sterilizer
    • Stakeholders Anticipate FDA Action on Third-Party Repairs
    • Nelson Laboratories, Healthmark Collaborate on Duodenoscope Testing
    Dan Floyd and Paul Littley , Nelson Laboratories Inc.04.06.16
    The first question that comes to mind after completing an ethylene oxide (EO) sterilization qualification is, “When do I need to perform a requalification study, and what will that entail?” The following is a comprehensive look at the typical validation approach, the factors that determine when requalification is necessary, and how the expectations in ANSI/AAMI/ISO 11135 have changed in recent years regarding requalification.

    Before looking at the requalification process, it is important to understand what is required to validate a sterilization process in the first place. Obviously, the goal is to develop and validate a repeatable sterilization process that consistently yields a sterility assurance level (SAL) of 10-6. Sterility can never be proven as an absolute; there is always a finite chance of a survivor in a sterilization process. Therefore, sterility is looked at in terms of probability. What is the probability of a non-sterile unit in a given process? An SAL of 10-6 is the probability of one unit in one million being non sterile and is the U.S. Food and Drug Administration (FDA)  requirement for terminally sterilized devices. This is recognized universally for most devices, although some applications may result in alternate sterility assurance levels such as an SAL of 10-3 (one unit in 1,000 being non-sterile, the level typically performed on some skin contacting devices). FDA guidance reiterates the requirement for a sterility assurance level of 10-6 in “Submission and Review of Sterility Information in Premarket Notification [510(k)] Submissions for Devices Labeled as Sterile/Guidance for Industry and Food and Drug Administration Staff” (Document Issued on Jan. 21, 2016). In this FDA guidance document, EO sterilization is classified as an “established” sterilization method. As such, the agency does not have specific requirements or documents that outline requirements for validation, but instead, FDA relies on recognized voluntary consensus standards.

    The most important FDA-recognized consensus standard that governs the EO sterilization of healthcare products is ANSI/AAMI/ISO 11135:2014 “Sterilization of health care products—Ethylene oxide—Requirements for development, validation and routine control of a sterilization process for medical devices.” The Association for the Advancement of Medical Instrumentation (AAMI) is an organization founded to set safety standards for the design and use of medical products. AAMI committees also develop the U.S. position on many international standards. In addition to standards, AAMI develops Technical Information Reports (TIR). These documents are not requirements but are designed to help the reader understand and meet the requirements outlined in normative standards.
    Several TIRs have been written to provide guidance on ANSI/AAMI/ISO 11135:2014. These include topics such as contract sterilization using EO (AAMI TIR 14:2009), physical aspects of EO sterilization (AAMI TIR 15:2009 (R)2013), microbiological aspects of EO sterilization (AAMI TIR 16:2009 (R)2013), and product adoption and process equivalence for EO sterilization (AAMI TIR 28:2009 (R)2013).

    A validation of the sterilization process, similar to most validations, consists of installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). The official definitions of IQ, OQ, and PQ are found in ISO/TS 11139:2006 “Sterilization of health care products—Vocabulary.” IQ is the process of obtaining and documenting evidence that equipment has been provided and installed in accordance with its specification. OQ is the process of obtaining and documenting evidence that installed equipment operates within predetermined limits when used in accordance with its operational procedures. PQ is the process of obtaining and documenting evidence that the equipment, as installed and operated in accordance with operational procedures, consistently performs in accordance with predetermined criteria and, thereby, yields product meeting the required specifications.

    EO sterilization most commonly follows the conventional release of product using the biological indicator overkill approach. This method is based on the concept that standardized biological indicators (BIs) placed within the product (or an appropriate PCD) are more resistant to EO sterilization than the natural bioburden contained on the product. Demonstrating kill of the highly resistant BIs in one-half of the cycle time provides a wide safety margin. Three half cycles, utilizing half the EO exposure time as the expected routine production cycle, are performed on the worst case loading configuration. The worst case load is defined as the product mix, product volume, and loading configuration that is the most difficult to sterilize.

    Following completion of the sterilization validation, the user will continue to sterilize product in routine production cycles until requalification is required. Which brings us back to the question, “When is requalification required, and what does it entail?”

    The industry expectation is that the user must perform a formal assessment of the original IQ, OQ, and PQ every year, as well as any subsequent qualification(s) to determine the extent of requalification that may be necessary. In many cases, small cumulative changes may be enough to make requalification necessary. Historically, it was common, if not expected, to perform a reduced requalification annually to detect inadvertent changes that may have gone undetected. A reduced requalification was generally a single half cycle to verify the process still delivered an SAL of 10-6. The 2007 revision of the ANSI/AAMI/ISO 11135 stated that requalification be performed at “defined intervals” without defining what the expectation was for the interval. This statement was open to interpretation, and some users went years between performing any actual requalification exercises. This practice could potentially lead to inadvertent changes adversely affecting the delivered SAL without user awareness. This can put patients at risk.

    The requirement for an annual formal assessment is a positive change and is an improvement in the current revision of ANSI/AAMI/ISO 11135:2014. It ensures a thorough review is always performed. It also recommends that no more than two years pass without performing an actual physical test cycle to verify that the process continues to yield an SAL of 10-6. This is necessary to detect the inadvertent changes that may have been missed in the annual written requalification assessment.

    The extent of requalification required is dependent on the changes that have taken place over the course of the year. Changes that have occurred in the manufacturing process, the product, the packaging, the sterilization equipment, and/or the sterilization cycle can all adversely affect the lethality of the cycle and may necessitate requalification. A formal documented assessment of all areas is required.

    The assessment starts first with a review of the IQ. This will look at the calibration of all sterilization and ancillary equipment that controls and monitors the sterilization process. Preventive maintenance, as well as non-scheduled maintenance, performed during the year will also be reviewed. Proper change control plays an important role in capturing critical changes. Remember, small cumulative changes may be enough to make requalification necessary.

    The OQ review will look at the performance of the equipment and most notably involves the empty chamber profile. Profiling the empty chamber involves placing temperature and humidity probes throughout the chamber and running preconditioning, sterilization, and aeration cycles. This will help to monitor performance and should compare the original validation to any subsequent requalification. These profiles are performed to detect any degradation in performance. Temperature and humidity are critical parameters for EO sterilization and must be controlled within predetermined limits. The requirement for the empty sterilization vessel during the exposure phase of the cycle is ±3 degrees Celsius of the average recorded temperature at each time point but, just as important as meeting this requirement, is the performance of the vessel over time to look for adverse trends.

    A review of the PQ should verify if any changes to the manufacturing environment or location have occurred. It should also check for changes to the product, packaging configuration, or loading configuration that may impede penetration of the sterilant into the hard-to-access areas of the device, as well changes to bioburden numbers and types. It is important to look for changes to the bioburden makeup because this can affect the resistance of the product to sterilization. In addition to the product, if a process challenge device (PCD) is used to monitor the sterilization process, the configuration components should be reviewed to ensure that changes have not occurred that may make the PCD less resistant than the actual product. A PCD is a item that mimics the resistance of the actual product and is used to monitor the efficacy of the sterilization process. To be an appropriate PCD, it must be demonstrated to have equivalent or greater resistance than the actual product.

    Finally, a review should be performed of any positive growth that occurred during sterility testing since the last qualification.

    Based on a review of the items that have been previously listed, an assessment must be made regarding the effect that any changes may have had on the efficacy of the sterilization process and if there have been any changes to the ability to yield the same desired sterility assurance level.

    There are multiple paths to follow when determining the extent of requalification that is needed. The first question that is asked after a thorough review of the manufacturing, the product, the packaging, or the sterilization process is if there have been any changes. If the answer to this question is yes, it must be determined if the changes identified are significant enough to affect the efficacy of the process. A sterilization specialist should make this determination. If the changes are judged to adversely affect the efficacy of the process, a full requalification must be performed. This would consist of a minimum of three half cycles of the load configuration judged most difficult to sterilize. In the event there is growth when the requalification is performed, the cycle parameters may need to be adjusted to make the cycle more lethal (i.e., increase in the temperature or lengthening of the exposure time). Three half cycles need to be successfully performed with the new parameters to demonstrate repeatability.

    If there have been changes to the product but the changes are judged not to be significant, a reduced requalification consisting of a minimum of a single half cycle should be performed to verify that the process still yields a sterility assurance level of 10-6.

    If the assessment indicates that no changes affecting the sterilization process have occurred and a requalification has been performed in the last two years, then a documented rationale will suffice for that year. A reduced requalification would then be performed the following year.

    If the assessment indicates that no changes have been made affecting the process and a requalification has not been performed in the last two years, then a reduced qualification consisting of a minimum of one half cycle is indicated.

    Some examples of major changes that would require requalification would be relocation of the manufacturing or sterilization site, sterilization failures that cannot be explained, or changes to the product or packaging that make the product more difficult to sterilize. Changes to the sterilization load or packaging density that would make the load itself more difficult to sterilize would also necessitate requalification. This is true even if the individual product has not changed. Additionally, an adverse change to the product bioburden in either numbers or resistance would also make requalification necessary.

    In summary, every year a formal requalification assessment is required to determine if changes have occurred that could affect a previously validated process. The amount of requalification necessary depends on if these changes are deemed significant enough to affect the ability of the process to deliver a sterility assurance level of 10-6. If the changes are minor, a reduced requalification can be performed. If the changes are significant, a full requalification would be required. A requalification half cycle must be performed every two years at a minimum. During the “off year,” a documented rationale covering all areas discussed may suffice if no changes have occurred. 


    Dan Floyd is a director of laboratory operations at Nelson Laboratories—a microbiological testing company specializing in improving the quality of life by ensuring medical products are safe, sterile, and functional. He is a recognized authority and industry leader on Ethylene Oxide (EO) sterilization, EO residuals, bioburden, microbiology, environmental control, packaging, and related material considerations for sterilization processes. Floyd has over 23 years of experience working in research, laboratory, product design, and manufacturing functions in the medical device and contract sterilization industries. He is actively involved in standards development. He is a member of the Association for the Advancement of Medical Instrumentation (AAMI) working groups for industrial ethylene oxide sterilization, biological indicators, process challenge devices (PCD), sterilization residuals, packaging, and resistometers. He is also a member of the American Society for Microbiology (ASM), a registered microbiologist with the National Registry of Certified Microbiologists (NRCM), and is a certified quality auditor with the American Society for Quality (ASQ).
       
    Paul Littley is a consulting manager at Nelson Laboratories. He has over 13 years in the medical device field, including 11 years of medical device industry experience working in sterility assurance, quality assurance, manufacturing, and research and development. His expertise includes ethylene oxide sterilization validation, USP grade water system design and validation, device reprocessing, cleaning validations, microbiology testing, and process validation and controls. Littley is an active committee member of multiple working groups with the Association for the Advancement of Medical Instrumentation. 
    Related Searches
    • Process Validation
    • quality
    • nelson laboratories
    • first
    Related Knowledge Center
    • R&D & Design
    • Testing
    • Contract Manufacturing
    Suggested For You
    Extractable/Leachable Chemistry Testing Strategies for Medical Devices Extractable/Leachable Chemistry Testing Strategies for Medical Devices
    Qosina Adds New Y Connector Hemostasis Valves Qosina Adds New Y Connector Hemostasis Valves
    TSO3 Receives U.S. Clearance for Extended Claims for Its Medical Device Sterilizer TSO3 Receives U.S. Clearance for Extended Claims for Its Medical Device Sterilizer
    Stakeholders Anticipate FDA Action on Third-Party Repairs Stakeholders Anticipate FDA Action on Third-Party Repairs
    Nelson Laboratories, Healthmark Collaborate on Duodenoscope Testing Nelson Laboratories, Healthmark Collaborate on Duodenoscope Testing
    Sterigenics International Buys Nelson Laboratories Sterigenics International Buys Nelson Laboratories
    FDA Encourages Human Factors Testing FDA Encourages Human Factors Testing
    Nelson Laboratories Honored as a Leader in Science and Technology Nelson Laboratories Honored as a Leader in Science and Technology
    Nelson Laboratories Gains Certification from Australia Nelson Laboratories Gains Certification from Australia's Therapeutic Goods Administration
    ConforMIS Faces Lawsuit Over Recent Device Recall ConforMIS Faces Lawsuit Over Recent Device Recall
    Sterigenics Expands Facility in West Memphis Sterigenics Expands Facility in West Memphis
    Recent ConforMIS Recall Leads to Lawsuit Recent ConforMIS Recall Leads to Lawsuit
    Sterilization and Packaging: New Trends, New Limits Sterilization and Packaging: New Trends, New Limits
    Testing: How to Approach Change in Orthopedic Device Manufacturing
Testing: How to Approach Change in Orthopedic Device Manufacturing
     Medline Launches Stronger Bonded Sterilization Wrap Medline Launches Stronger Bonded Sterilization Wrap

    Related Features

    • R&D & Design
      The Human Factors of Aesthetics

      The Human Factors of Aesthetics

      Exploring the relationship between a device’s aesthetic, human factors engineering, and purposeful design.
      Sean Hägen, Principal, Director of Research & Synthesis, BlackHägen Design 09.01.20

    • Testing
      Assessing Nanoparticles for Biocompatibility

      Assessing Nanoparticles for Biocompatibility

      It is important to have an appropriate testing protocol in place for this relatively new medical technology.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Laboratories 09.01.20

    • Contract Manufacturing
      Automatic Pilot: Automation Provides Solutions for Assembly Challenges

      Automatic Pilot: Automation Provides Solutions for Assembly Challenges

      Assembly and automation experts discuss the market forces and technology trends affecting the industries.
      Sam Brusco, Associate Editor 09.01.20


    • R&D & Design
      Current State of (Design) Mind

      Current State of (Design) Mind

      Medtech designers have an array of new tools to use for medical device development, enabling better solutions for healthcare.
      Mark Crawford, Contributing Writer 05.01.20

    • Contract Manufacturing
      Contract Partners: A Discussion of Full Service Outsourcing

      Contract Partners: A Discussion of Full Service Outsourcing

      Today’s outsourcing providers are more than just “hired help”; they serve as an extension of an OEM’s capabilities.
      Sean Fenske, Editor-in-Chief 05.01.20

    • R&D & Design
      Examining the Usability of Medical Software

      Examining the Usability of Medical Software

      Developers need to consider the ‘human factor’ when it comes to testing medical device software.
      Bruce Johnston, Senior Software Engineering Specialist, MedAcuity Software 04.01.20


    • R&D & Design
      Four Considerations for Developers of Next-Generation Combination Products

      Four Considerations for Developers of Next-Generation Combination Products

      Bringing together real-time monitoring, telemedicine, AI, interventions, and pharmaceuticals into a single device produces a number of potential pitfalls.
      Mark Goodman and Barry Thompson, Baker & McKenzie LLP 03.04.20

    • Testing
      Testing in Flux: Changing Protocols for a Transformative Industry

      Testing in Flux: Changing Protocols for a Transformative Industry

      As regulations and requirements around the world change, so too do the testing protocols for medical devices, sending OEMs to consult expert partners.
      Mark Crawford, Contributing Writer 03.04.20

    • R&D & Design
      Inventive Interaction: Medtech Research and Development in 2020

      Inventive Interaction: Medtech Research and Development in 2020

      Engaging with all stakeholders—patients, clinicians, and community members alike—is key to effective medtech R&D.
      Michael Barbella, Managing Editor 01.29.20


    • Contract Manufacturing | Materials | R&D & Design
      Delivering the Goods: The Evolving World of Combination Products

      Delivering the Goods: The Evolving World of Combination Products

      This extremely diverse market fosters relationships between medical device and pharmaceutical companies.
      Sam Brusco, Associate Editor 11.04.19

    • Contract Manufacturing
      Assembling with Reliability and Repeatability Through Automation

      Assembling with Reliability and Repeatability Through Automation

      Progress in assembly and automation technologies enable manufacturers to leverage capabilities such as Industry 4.0 and IoT for medical device fabrication.
      Mark Crawford, Contributing Writer 09.09.19

    • Contract Manufacturing | Electronics | Neurological
      Shock to the System: An Examination of Neurostim Technologies

      Shock to the System: An Examination of Neurostim Technologies

      Targeted electrical nerve stimulation technology can aid in chronic disease management by improving on current treatment methods.
      Sam Brusco, Associate Editor 09.09.19


    • Cardiovascular | Contract Manufacturing | Diagnostics | Digital Health | Electronics | Neurological | Patient Monitoring | R&D & Design
      Customized Connections: A Discussion on Custom Electronics

      Customized Connections: A Discussion on Custom Electronics

      Demand for more complex, traceable, integrated solutions are driving innovation in the fast-changing medical electronics market.
      Michael Barbella, Managing Editor 09.09.19

    • R&D & Design
      Consumer-Minded Design

      Consumer-Minded Design

      OEMs are requiring design partners to put more focus on user interface and aesthetics as they seek to produce devices intended to be used directly by patients.
      Mark Crawford , Contributing Writer 05.01.19

    • Contract Manufacturing
      An Extension of Reach: A Discussion of Full-Service Outsourcing

      An Extension of Reach: A Discussion of Full-Service Outsourcing

      OEMs recognize outsourcing service providers as opportunities for cutting costs and improving time to market while maintaining quality of product.
      Sean Fenske, Editor-in-Chief 05.01.19


    Trending
    • Senseonics Forges Strategic Collaboration With Ascensia Diabetes Care
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Henry Schein Buys Majority Interest In Prism Medical Products
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    Breaking News
    • Spectrum Solutions Collaborates with UCLA School of Dentistry
    • Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization
    • Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty
    • Twist on Heart Valve Design Boosts Blood Flow, Prevents Clots
    • FDA Clears 3D Acellular Dermal Matrix
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PepsiCo and Beyond Meat Partner to Develop Plant-Based Protein
    New Study on Sage Extract Formula Suggests Memory Enhancement
    Omega-3s Evidenced to Reduce Low-Grade Inflammation in Elderly Men
    Coatings World

    Latest Breaking News From Coatings World

    Mayzo Makes 2 Appointments
    Mississippi Lime Company Announces New Director of Safety
    IFS Coatings Launches IFS Puroplaz PE20 Texture
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Spectrum Solutions Collaborates with UCLA School of Dentistry
    Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization
    Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
    Novartis Invests in Credence MedSystems
    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty to Shut Down Manufacturing Site in Cologne, Germany
    L’Occitane Files for Bankruptcy in U.S.
    Bésame Cosmetics Collaborates with Disney on Mary Poppins Collection
    Happi

    Latest Breaking News From Happi

    CLT Introduces Private Label Solid Air Freshener Cones
    The Florida Sunscreen Symposium Is Back!
    TFF Opens Nominations for 2021 Awards
    Ink World

    Latest Breaking News From Ink World

    Epson Partner Creates Label Applicators for Pharmaceutical Products
    Smurfit Kappa Sets New Sustainability Targets with Better Planet 2050
    Georgia-Pacific Acquires 3rd HP PageWide Corrugated Press to Expand Hummingbird Digital Printing
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex acquires MDV Group
    Fix-A-Form eyes global expansion
    McCracken Label installs Fujifilm water-wash plate system
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Nice-Pak Receives EPA Approval for Disinfecting Wipes
    Rockline to Invest $18 Million in Arkansas
    Essity’s Sales Negatively Impacted by Covid-19 Pandemic
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ChoiceSpine's Tiger Shark Cervical Spacer Earns Additional 510(k)
    FDA Green Lights Inspired Spine's Trident SI Joint Screw System
    FDA Clears Method to Extract Bone Measurements From X-Rays
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Osram Sees Jump in Profits in Preliminary 2020 Report
    LG Display Reports 4Q 2020 Results
    Xerox Releases 4Q, Full Year Results

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login